Thrombosis and Haemostasis

Issue S 01 · Volume 118 · May 2018 DOI: 10.1055/s-008-40847

Foreword

Camm, A. John: The Evolution of Antithrombotic Care in Cardiovascular Patients

Full Text
HTML
PDF (37 kb)

Review Article

Camm, A. John: The Rivaroxaban Program and the Management of Unmet Needs in Thromboembolic Disease

Full Text
HTML
PDF (296 kb)

S12

Bauersachs, Rupert; Zannad, Faiez: Rivaroxaban: A New Treatment Paradigm in the Setting of Vascular Protection?

Full Text
HTML
PDF (410 kb)

S23

Khorana, Alok A.; Weitz, Jeffrey I.: Treatment Challenges in Venous Thromboembolism: An Appraisal of Rivaroxaban Studies

Full Text
HTML
PDF (269 kb)

S34

Gibson, C. M.; Hankey, G. J.; Nafee, T.; Welsh, R. C.: Beyond Stroke Prevention in Atrial Fibrillation: Exploring Further Unmet Needs with Rivaroxaban

Full Text
HTML
PDF (318 kb)

S45

Camm, A. John; Coleman, Craig I.; Larsen, Torben Bjerregaard; Nielsen, Peter Brønnum; Tamayo, CAPT Sally: Understanding the Value of Real-World Evidence: Focus on Stroke Prevention in Atrial Fibrillation with Rivaroxaban

Full Text
HTML
PDF (244 kb)